Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study

• Samir K. Gupta ,

  * E-mail: sgupta1@iupui.edu

  Affiliation Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Changyu Shen,

  Affiliation Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Sharon M. Moe,

  Affiliation Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Lisa M. Kamendulis,

  Affiliation Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America

  ⨯
• Mitchell Goldman,

  Affiliation Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Michael P. Dubé

  Affiliation Division of Infectious Diseases, Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, United States of America

  ⨯